Cancer, Reproductive, Cardiovascular, and Other Chronic Disease Prevention Program
The Cancer, Reproductive, Cardiovascular, and Other Chronic Disease Prevention Program (CRC) provides leadership in the prevention of a number of different work-related diseases and conditions. The CRC Program works with partners in industry, labor, trade associations, professional organizations, and academia focusing on preventing and reducing: (1) occupational cancer; (2) adverse reproductive outcomes related to work; (3) cardiovascular disease (CVD) among workers; and (4) occupational neurologic and renal disease.
Workplace exposures to hazardous drugs can cause both acute and chronic health effects such as adverse reproductive outcomes (including infertility, spontaneous abortions, and congenital malformations) and possibly leukemia and other cancers. Health care workers who prepare or administer hazardous drugs (e.g., those used for cancer therapy, and some antiviral drugs, hormone agents, and bioengineered drugs) or who work in areas where these drugs are used may be exposed to these agents in the workplace.
The NIOSH Alert “Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Healthcare Settings” was published in September 2004. NIOSH periodically updates its list of hazardous drugs. The 2016 update – “NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016”, (DHHS [NIOSH] Publication Number 2016-161) – has been completed and is available here. Further information is available at the NIOSH “Hazardous Drug Exposures in Health Care” Topic Page.
- Page last reviewed: May 31, 2017
- Page last updated: July 28, 2017
- Content source:
- National Institute for Occupational Safety and Health Office of the Director